Company Directory - Pharmaco

Immuron Limited is a commercial and clinical stage publicly listed Australian biopharmaceutical company with a proprietary technology platform focused on the development and commercialization of a novel class of specifically targeted polyclonal antibodies that we believe can address significant unmet medical needs.

Insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europe and in Japan.

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada.

The Netherlands-based Intravacc is one of the world’s leading institutes for translational vaccinology.

Ionis is THE leading innovator in RNA-targeted therapeutics and was purposely designed to: Create a better, more efficient drug discovery platform, Establish a new innovation-centered business model, and Maximize the value of every medicine we create and get it to the people who need it most as quickly and as efficiently as possible.

A leading biopharmaceutical group dedicated to prolonging and improving lives and health outcomes through innovative medicines in oncology, neuroscience and rare disease. We also have a well-established and successful Consumer Healthcare business.

Key Pharmaceuticals has been involved in the development, manufacture and regulatory support of generic pharmaceuticals for 20 years. Through our technical knowledge and regulatory expertise, we have successfully developed, registered and launched 22 generic drugs in the UK, with many more in the pipeline.

Kroyf Labcorp is a leading pharma franchise company with over 10 years of trusted experience in the pharmaceutical industry. They specialize in delivering high-quality, affordable, and innovative healthcare solutions.

Kuste Biopharma is a new biopharmaceutical Clinical Stage company founded by seasoned life sciences entrepreneurs. The company owns therapeutic compounds for inflammatory diseases, with molecules having achieved extensive phase 3 results in the field of eye and ear inflammation.

Linical is a global speciality CRO headquartered in Osaka, Japan, listed in the prime segment of the Tokyo Stock exchange, and dedicated to serve its clients as a true partner in development.

We a leading global life science company with a more than 50-year legacy of delivering answers for crucial health questions—because we know that knowledge has the potential to make life better for all.

Lexicon Pharmaceuticals is a biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic conditions.

For more than 140 years, we’ve been creating medicines that make life better. We pursue pharmaceutical innovation, provide high-quality products and strive to deliver superior business results.

Losan is a pharma-technology company focused on the development and manufacture of cutting-edge medicinal products with improved API performance and/or convenient application.

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with brain diseases. For this purpose, Lundbeck is engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world.

Marinomed Biotech AG is a biopharmaceutical company. It specializes in the development of innovative products based on patent protected technology platforms in the field of respiratory and ophthalmic diseases. Marinomed has received multiple prestigious research awards for its activities.